ROLFE LINDSEY (See Remarks) sold 3.6% of their position (4.26K shares) of CLOVIS ONCOLOGY, INC. on the open market
Open‑market sale worth $4.2K — a minor trim. Review remaining holdings and any 10b5‑1 plan disclosures.
S · 2 sales
Filed: 11/3/2022ACC: 0000899243-22-034890
Officer· See Remarks
Since Sep 2018
-4.26K
Net shares
Net seller
$4.2K
Total sold
2
Open market trades
0B · 2S
6
Total transactions
8.37K acquired · 12.63K disposed
Non-Derivative Transactions4
Common Stock
Direct
Shares
+3.75K
Price / share
—
Trade value
—
% of position
3.4%
11/1/2022
109.58K→113.33K
Common Stock
Direct
Shares
+4.63K
Price / share
—
Trade value
—
% of position
4.2%
11/1/2022
111.42K→116.04K
Common Stock
Direct
Shares
−1.91K
Price / share
$0.98
Trade value
$1.88K
% of position
1.7%
11/2/2022
113.33K→111.42K
Common Stock
Direct
Shares
−2.35K
Price / share
$0.98
Trade value
$2.31K
% of position
2.0%
11/2/2022
116.04K→113.69K
Total
Net shares
+4.11K
Net value
-$4.19K
| Security | Date | Type | Shares | Price / Share | Trade Value | % of Position | Held Before | Held After |
|---|---|---|---|---|---|---|---|---|
| Common Stock Direct | 11/1/2022 | M · Option Exercise | +3.75K | — | — | 3.4% | 109.58K | 113.33K |
| Common Stock Direct | 11/1/2022 | M · Option Exercise | +4.63K | — | — | 4.2% | 111.42K | 116.04K |
| Common Stock Direct | 11/2/2022 | S · Sale | −1.91K | $0.98 | $1.88K | 1.7% | 113.33K | 111.42K |
| Common Stock Direct | 11/2/2022 | S · Sale | −2.35K | $0.98 | $2.31K | 2.0% | 116.04K | 113.69K |
| Total | +4.11K | -$4.19K | ||||||
Derivative Transactions2
Restricted Stock Units
Direct
Converts to
Common Stock
3.75K shares
Shares
−3.75K
Strike price
Held after
3.75K
Exercisable
—
11/1/2022
Restricted Stock Units
Direct
Converts to
Common Stock
4.63K shares
Shares
−4.63K
Strike price
Held after
23.13K
Exercisable
—
11/1/2022
| Security | Converts To | Date | Type | Shares | Strike Price | Exercisable | Held After |
|---|---|---|---|---|---|---|---|
| Restricted Stock Units Direct | Common Stock3.75K shares | 11/1/2022 | M · Option Exercise | −3.75K | — | 3.75K | |
| Restricted Stock Units Direct | Common Stock4.63K shares | 11/1/2022 | M · Option Exercise | −4.63K | — | 23.13K |